[Occurrence of Distant Metastasis During Bladder Presevation in T1 high-grade Bladder Cancer: Report of Three Cases].

Chul Jang Kim, Haruna Ide, Masatoshi Nakamura, Eiki Hanada
{"title":"[Occurrence of Distant Metastasis During Bladder Presevation in T1 high-grade Bladder Cancer: Report of Three Cases].","authors":"Chul Jang Kim,&nbsp;Haruna Ide,&nbsp;Masatoshi Nakamura,&nbsp;Eiki Hanada","doi":"10.14989/ActaUrolJap_69_9_249","DOIUrl":null,"url":null,"abstract":"<p><p>We report three patients with T1 high-grade (HG) bladder cancer who suffered from distant metastasis during bladder preservation. The patients were a 48-year-old female (Case 1), a 75-year-old female (Case 2) and an 82-year-old male (Case 3) with the chief complaint of asymptomatic gross hematuria. The histopathological diagnoses of the initial transurethral resection of the bladder tumor (TURBT) and second TURBT were urothelial carcinoma, pT1, HG and no malignancy in all three patients. Bladder tumors of all patients revealed sessile growth pattern and no presence of carcinoma in situ. Case 2 and 3 did not receive BCG vesical instillation after the second TURBT. Lymph node metastases appeared in Case 1 and Case 2 and lung metastasis appeared in Case 3. Tumor budding (TB) was positive in Case 1 and Case 2. Variant histology (VH) of nested morphology was detected in Case 1 and VH of inverted morphology in Case 2 and Case 3. Twenty-four months after the initial TURBT, Case 1 died due to cancer progression after cisplatin-based chemotherapy and pembrolizumab therapy. Thirty-three and 11 months after the initial TURBT, Case 2 and Case 3 were alive without cancer progression after cisplatin-based chemotherapy and/or pembrolizumab therapy, respectively. The two patients with T1 HG bladder cancer with TB had lymphatic metastasis and the patient without TB had hematogenous metastasis. Nested morphology is reportedly categorized as high-risk disease and inverted morphology as low-risk disease. TB might be correlated with lymphatic metastasis in T1 HG bladder cancer, and TB should be considered in the management of T1 HG bladder cancer. In the case of VH, the guidelines should be followed during the treatment decision of T1 HG bladder cancer.</p>","PeriodicalId":39291,"journal":{"name":"Acta Urologica Japonica","volume":"69 9","pages":"249-254"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Urologica Japonica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14989/ActaUrolJap_69_9_249","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

We report three patients with T1 high-grade (HG) bladder cancer who suffered from distant metastasis during bladder preservation. The patients were a 48-year-old female (Case 1), a 75-year-old female (Case 2) and an 82-year-old male (Case 3) with the chief complaint of asymptomatic gross hematuria. The histopathological diagnoses of the initial transurethral resection of the bladder tumor (TURBT) and second TURBT were urothelial carcinoma, pT1, HG and no malignancy in all three patients. Bladder tumors of all patients revealed sessile growth pattern and no presence of carcinoma in situ. Case 2 and 3 did not receive BCG vesical instillation after the second TURBT. Lymph node metastases appeared in Case 1 and Case 2 and lung metastasis appeared in Case 3. Tumor budding (TB) was positive in Case 1 and Case 2. Variant histology (VH) of nested morphology was detected in Case 1 and VH of inverted morphology in Case 2 and Case 3. Twenty-four months after the initial TURBT, Case 1 died due to cancer progression after cisplatin-based chemotherapy and pembrolizumab therapy. Thirty-three and 11 months after the initial TURBT, Case 2 and Case 3 were alive without cancer progression after cisplatin-based chemotherapy and/or pembrolizumab therapy, respectively. The two patients with T1 HG bladder cancer with TB had lymphatic metastasis and the patient without TB had hematogenous metastasis. Nested morphology is reportedly categorized as high-risk disease and inverted morphology as low-risk disease. TB might be correlated with lymphatic metastasis in T1 HG bladder cancer, and TB should be considered in the management of T1 HG bladder cancer. In the case of VH, the guidelines should be followed during the treatment decision of T1 HG bladder cancer.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[T1高级别膀胱癌症术前膀胱远端转移的发生:附3例报告]。
我们报告了3例T1高级别(HG)癌症患者,他们在膀胱保存过程中发生了远处转移。患者为48岁女性(病例1)、75岁女性(案例2)和82岁男性(病例3),主要主诉为无症状肉眼血尿。首次经尿道膀胱肿瘤切除术(TURBT)和第二次TURBT的组织病理学诊断为尿路上皮癌、pT1、HG,三名患者均无恶性肿瘤。所有患者的膀胱肿瘤均显示固着生长模式,未发现原位癌。病例2和3在第二次TURBT后未接受BCG膀胱滴注。病例1和病例2出现淋巴结转移,病例3出现肺转移。在病例1和病例2中,肿瘤出芽(TB)呈阳性。在病例1中检测到嵌套形态的变异组织学(VH),在病例2和病例3中检测到倒置形态的VH。首次TURBT后20个月,病例1在顺铂化疗和pembrolizumab治疗后因癌症进展而死亡。在首次TURBT后的第三十三个月和第十一个月,病例2和病例3分别在基于顺铂的化疗和/或pembrolizumab治疗后存活,没有癌症进展。两例T1 HG膀胱癌症伴结核患者有淋巴结转移,一例无结核患者有血行转移。据报道,巢状形态被归类为高风险疾病,而倒置形态则被归类为低风险疾病。结核可能与T1 HG膀胱癌症的淋巴结转移有关,在T1 HG癌症的治疗中应考虑结核。在VH的情况下,在决定T1 HG膀胱癌症的治疗过程中应遵循指南。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta Urologica Japonica
Acta Urologica Japonica Medicine-Medicine (all)
CiteScore
0.20
自引率
0.00%
发文量
74
期刊最新文献
[The Case of Solitary Adrenal Metastasis of Urothelial Carcinoma]. [The Introduction of Pubic Hair into the Bladder : A Possibility of an Alternate Mechanism]. [A Case of Metastatic Testicular Cancer after Kidney Transplantation in which Complete Remission was Achieved]. [A Case of Pelvic Arteriovenous Malformation in a Male with Massive Bladder Bleeding which Caused Severe Hemorrhagic Hypovolemic Shock]. [Risk Factor of Cutaneous Symptoms Associated with Enfortumab Vedotin for Urothelial Carcinoma].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1